Clinical Trials in Chicago

Showing 6861-6880 of 15,574 trials

Efficacy of Naltrexone in Women's Smoking Cessation

NCT00271024

The purpose of the proposed study is to conduct a randomized, double-blind clinical trial to compare adjunct treatment with 50 mg oral naltrexone vs. placebo in conjunction with standard smoking cessation treatment with nicotine patch and counseling. Hypotheses: 1. Naltrexone will improve smoking cessation quit rates, as measured at the end of active treatment (3 months) and during long term follow up (1 year). 2. Weight and smoking-related variables (i.e., less weight gain, as well as reduced craving and withdrawal) will be important factors by which naltrexone improves smoking cessation outcome. 3. These effects are predicted to be stronger in women compared to men.

SmokingSmoking Cessation

University of Chicago333 participantsStarted Dec 2005

Chicago, Illinois, United States

TERMINATEDNA2.2 miles

OPTIMIZE IDE for the Treatment of ACS

NCT03190473

Indication for use: "The Svelte DES is indicated for improving coronary luminal diameter in patients with symptomatic heart disease, including patients with non-ST elevation MI due to discrete de novo native coronary artery lesions. The treated lesion length should be less than the nominal stent length with a reference vessel diameter of 2.25 mm - 4.00 mm

Acute Coronary Syndrome

Svelte Medical Systems, Inc.1,630 participantsStarted Jan 2018

Fairhope, Alabama, United States • Scottsdale, Arizona, United States • Little Rock, Arkansas, United States +69 more locations

Efficacy of Naltrexone in Women's Smoking Cessation

OPTIMIZE IDE for the Treatment of ACS

Find Trials by Condition in Chicago

Bioavailability of EPA + DHA in a SMEDS Formulation

Evaluation of the CleanSweep™ Closed Suction System on Length of Mechanical Ventilation and Ventilator-Associated Events

Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma

A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety

First in Human Study of M4344 in Participants With Advanced Solid Tumors

Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy

A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal

(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies

A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.

Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation

A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis

N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers

Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study

A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

Rituximab Plus Venetoclax in Combination With Zandelisib in Subjects With CLL

The TREFOIL Concept 5 Year Clinical Investigation